Cargando…

Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer

Background. The aim of this study is to detect possible risk factors for development of short- and long-term local complications after inguinofemoral lymphadenectomy for vulval cancer. Methods. This retrospective cohort study included 34 vulval cancer patients that received inguinofemoral lymphadene...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, A. A., Heubner, M., Kimmig, R., Wimberger, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259693/
https://www.ncbi.nlm.nih.gov/pubmed/22262953
http://dx.doi.org/10.1100/2012/341253
_version_ 1782221414369067008
author Soliman, A. A.
Heubner, M.
Kimmig, R.
Wimberger, P.
author_facet Soliman, A. A.
Heubner, M.
Kimmig, R.
Wimberger, P.
author_sort Soliman, A. A.
collection PubMed
description Background. The aim of this study is to detect possible risk factors for development of short- and long-term local complications after inguinofemoral lymphadenectomy for vulval cancer. Methods. This retrospective cohort study included 34 vulval cancer patients that received inguinofemoral lymphadenectomy. The detected complications were wound cellulitis, wound seroma formation, wound breakdown, wound infection, and limb lymphoedema. Followup of the patient ran up to 84 months after surgery. Results. Within a total of 64 inguinofemoral lymphadenectomies, 24% of the inguinal wounds were affected with cellulitis, 13% developed a seroma, 10% suffered wound breakdown, 5% showed lower limb edema within a month of the operation, and 21.4% showed lower limb edema during the long-term followup. No significant correlation could be found between saphenous vein ligation and the development of any of the local complications. The 3-year survival rate in our cohort was 89.3%. Conclusions. Local complications after inguino-femoral lymphadenectomy are still very high, with no single pre-, intra-, or postoperative factor that could be incriminated. Saphenous vein sparing provided no significant difference in decreasing the rate of local complications. More trials should be done to study the sentinel lymph node detection technique.
format Online
Article
Text
id pubmed-3259693
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Scientific World Journal
record_format MEDLINE/PubMed
spelling pubmed-32596932012-01-19 Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer Soliman, A. A. Heubner, M. Kimmig, R. Wimberger, P. ScientificWorldJournal Clinical Study Background. The aim of this study is to detect possible risk factors for development of short- and long-term local complications after inguinofemoral lymphadenectomy for vulval cancer. Methods. This retrospective cohort study included 34 vulval cancer patients that received inguinofemoral lymphadenectomy. The detected complications were wound cellulitis, wound seroma formation, wound breakdown, wound infection, and limb lymphoedema. Followup of the patient ran up to 84 months after surgery. Results. Within a total of 64 inguinofemoral lymphadenectomies, 24% of the inguinal wounds were affected with cellulitis, 13% developed a seroma, 10% suffered wound breakdown, 5% showed lower limb edema within a month of the operation, and 21.4% showed lower limb edema during the long-term followup. No significant correlation could be found between saphenous vein ligation and the development of any of the local complications. The 3-year survival rate in our cohort was 89.3%. Conclusions. Local complications after inguino-femoral lymphadenectomy are still very high, with no single pre-, intra-, or postoperative factor that could be incriminated. Saphenous vein sparing provided no significant difference in decreasing the rate of local complications. More trials should be done to study the sentinel lymph node detection technique. The Scientific World Journal 2012-01-04 /pmc/articles/PMC3259693/ /pubmed/22262953 http://dx.doi.org/10.1100/2012/341253 Text en Copyright © 2012 A. A. Soliman et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Soliman, A. A.
Heubner, M.
Kimmig, R.
Wimberger, P.
Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title_full Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title_fullStr Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title_full_unstemmed Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title_short Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
title_sort morbidity of inguinofemoral lymphadenectomy in vulval cancer
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259693/
https://www.ncbi.nlm.nih.gov/pubmed/22262953
http://dx.doi.org/10.1100/2012/341253
work_keys_str_mv AT solimanaa morbidityofinguinofemorallymphadenectomyinvulvalcancer
AT heubnerm morbidityofinguinofemorallymphadenectomyinvulvalcancer
AT kimmigr morbidityofinguinofemorallymphadenectomyinvulvalcancer
AT wimbergerp morbidityofinguinofemorallymphadenectomyinvulvalcancer